Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.805 | 3.45e-15 | 6.88e-04 | 4.35e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
EP300 | 2033 | 22 | -2.274 | 3.120 | 415 | Yes | Yes |
[ MITF ] | 4286 | 1 | -1.458 | 2.805 | 30 | - | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
SPI1 | 6688 | 2 | -2.003 | 2.870 | 115 | Yes | Yes |
MAPK14 | 1432 | 4 | -1.902 | 2.955 | 272 | - | - |
SON | 6651 | 9 | -3.844 | 3.108 | 9 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
TFEB | 7942 | 1 | -1.953 | 2.805 | 4 | - | - |
SUMO1 | 7341 | 7 | -1.696 | 3.050 | 439 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
MAPK14 | 1432 | MITF | 4286 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
MAPK14 | 1432 | DDIT3 | 1649 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro |
SON | 6651 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
EP300 | 2033 | MITF | 4286 | pp | -- | int.I2D: HPRD; int.Ravasi: -; int.HPRD: in vitro, in vivo |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MITF | 4286 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MITF | 4286 | SPI1 | 6688 | pp | -- | int.I2D: BioGrid, HPRD; int.Ravasi: -; int.HPRD: in vivo |
HNRNPU | 3192 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
POU5F1 | 5460 | SPI1 | 6688 | pp | -- | int.Mysickova: lymph_node |
MITF | 4286 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
DDIT3 | 1649 | EP300 | 2033 | pp | -- | int.Intact: MI:0915(physical association) |
EP300 | 2033 | HNRNPU | 3192 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vitro, in vivo |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
POU5F1 | 5460 | TFEB | 7942 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MITF | 4286 | TFEB | 7942 | pp | -- | int.I2D: HPRD; int.Transfac: -; int.Ravasi: -; int.HPRD: in vivo |
EP300 | 2033 | YAP1 | 10413 | pp | -- | int.I2D: BioGrid |
POU5F1 | 5460 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid, BioGrid_Mouse |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005654 | nucleoplasm | 1.03e-07 | 1.49e-03 | 3.099 | 9 | 64 | 1082 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.73e-07 | 2.50e-03 | 3.385 | 8 | 41 | 789 |
GO:0006355 | regulation of transcription, DNA-templated | 1.05e-06 | 1.51e-02 | 3.047 | 8 | 43 | 997 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.43e-06 | 2.06e-02 | 3.883 | 6 | 30 | 419 |
GO:0051525 | NFAT protein binding | 8.74e-06 | 1.26e-01 | 8.687 | 2 | 2 | 5 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 9.42e-06 | 1.36e-01 | 6.134 | 3 | 4 | 44 |
GO:0044212 | transcription regulatory region DNA binding | 1.62e-05 | 2.34e-01 | 4.616 | 4 | 17 | 168 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.73e-05 | 3.93e-01 | 3.145 | 6 | 39 | 699 |
GO:0005634 | nucleus | 4.51e-05 | 6.50e-01 | 1.439 | 12 | 159 | 4559 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.78e-05 | 9.78e-01 | 7.308 | 2 | 2 | 13 |
GO:0008134 | transcription factor binding | 6.78e-05 | 9.78e-01 | 4.090 | 4 | 18 | 242 |
GO:0005515 | protein binding | 1.00e-04 | 1.00e+00 | 1.153 | 13 | 198 | 6024 |
GO:0000123 | histone acetyltransferase complex | 1.82e-04 | 1.00e+00 | 6.616 | 2 | 6 | 21 |
GO:0030316 | osteoclast differentiation | 2.00e-04 | 1.00e+00 | 6.549 | 2 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.00e-04 | 1.00e+00 | 6.549 | 2 | 4 | 22 |
GO:0003723 | RNA binding | 2.58e-04 | 1.00e+00 | 3.591 | 4 | 18 | 342 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4.88e-04 | 1.00e+00 | 4.227 | 3 | 12 | 165 |
GO:0016607 | nuclear speck | 5.51e-04 | 1.00e+00 | 4.167 | 3 | 12 | 172 |
GO:0003677 | DNA binding | 5.94e-04 | 1.00e+00 | 2.343 | 6 | 49 | 1218 |
GO:0035019 | somatic stem cell maintenance | 6.68e-04 | 1.00e+00 | 5.687 | 2 | 6 | 40 |
GO:0007519 | skeletal muscle tissue development | 6.68e-04 | 1.00e+00 | 5.687 | 2 | 2 | 40 |
GO:0043966 | histone H3 acetylation | 8.46e-04 | 1.00e+00 | 5.517 | 2 | 5 | 45 |
GO:0001047 | core promoter binding | 8.46e-04 | 1.00e+00 | 5.517 | 2 | 5 | 45 |
GO:2000016 | negative regulation of determination of dorsal identity | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:1901985 | positive regulation of protein acetylation | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0043969 | histone H2B acetylation | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060177 | regulation of angiotensin metabolic process | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:2000629 | negative regulation of miRNA metabolic process | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0008380 | RNA splicing | 1.25e-03 | 1.00e+00 | 3.761 | 3 | 22 | 228 |
GO:0003713 | transcription coactivator activity | 1.39e-03 | 1.00e+00 | 3.705 | 3 | 24 | 237 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.45e-03 | 1.00e+00 | 5.126 | 2 | 6 | 59 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 1.55e-03 | 1.00e+00 | 5.078 | 2 | 4 | 61 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.76e-03 | 1.00e+00 | 2.854 | 4 | 37 | 570 |
GO:0060242 | contact inhibition | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0090241 | negative regulation of histone H4 acetylation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 2 |
GO:0019046 | release from viral latency | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 2 |
GO:0090204 | protein localization to nuclear pore | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0090043 | regulation of tubulin deacetylation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 2 |
GO:0071389 | cellular response to mineralocorticoid stimulus | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0014737 | positive regulation of muscle atrophy | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0035984 | cellular response to trichostatin A | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 2.27e-03 | 1.00e+00 | 4.799 | 2 | 4 | 74 |
GO:0044822 | poly(A) RNA binding | 2.39e-03 | 1.00e+00 | 2.286 | 5 | 50 | 1056 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0001650 | fibrillar center | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0090400 | stress-induced premature senescence | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0044027 | hypermethylation of CpG island | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 3.05e-03 | 1.00e+00 | 4.582 | 2 | 8 | 86 |
GO:0010467 | gene expression | 3.16e-03 | 1.00e+00 | 2.623 | 4 | 45 | 669 |
GO:0003682 | chromatin binding | 3.49e-03 | 1.00e+00 | 3.241 | 3 | 19 | 327 |
GO:0051726 | regulation of cell cycle | 3.86e-03 | 1.00e+00 | 4.409 | 2 | 5 | 97 |
GO:0097157 | pre-mRNA intronic binding | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0030098 | lymphocyte differentiation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0030578 | PML body organization | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0018393 | internal peptidyl-lysine acetylation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0045646 | regulation of erythrocyte differentiation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 5 |
GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 5 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0060033 | anatomical structure regression | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0065004 | protein-DNA complex assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0060298 | positive regulation of sarcomere organization | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0046983 | protein dimerization activity | 5.66e-03 | 1.00e+00 | 4.126 | 2 | 5 | 118 |
GO:0006325 | chromatin organization | 5.66e-03 | 1.00e+00 | 4.126 | 2 | 12 | 118 |
GO:0050733 | RS domain binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 3 | 6 |
GO:0002320 | lymphoid progenitor cell differentiation | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:1902262 | apoptotic process involved in patterning of blood vessels | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.71e-03 | 1.00e+00 | 2.904 | 3 | 24 | 413 |
GO:0045814 | negative regulation of gene expression, epigenetic | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 7 |
GO:0006475 | internal protein amino acid acetylation | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0045670 | regulation of osteoclast differentiation | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 8 |
GO:0001955 | blood vessel maturation | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 8.66e-03 | 1.00e+00 | 3.809 | 2 | 6 | 147 |
GO:0035259 | glucocorticoid receptor binding | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0045793 | positive regulation of cell size | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:0060765 | regulation of androgen receptor signaling pathway | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0048188 | Set1C/COMPASS complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 9 |
GO:0006983 | ER overload response | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0030851 | granulocyte differentiation | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0032495 | response to muramyl dipeptide | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 9 |
GO:0006974 | cellular response to DNA damage stimulus | 9.12e-03 | 1.00e+00 | 3.770 | 2 | 7 | 151 |
GO:0035413 | positive regulation of catenin import into nucleus | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 10 |
GO:0016407 | acetyltransferase activity | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 10 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.00e-02 | 1.00e+00 | 2.693 | 3 | 24 | 478 |
GO:0045663 | positive regulation of myoblast differentiation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 3 | 11 |
GO:0019395 | fatty acid oxidation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 11 |
GO:0004707 | MAP kinase activity | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0043923 | positive regulation by host of viral transcription | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0019789 | SUMO ligase activity | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 3 | 11 |
GO:0042975 | peroxisome proliferator activated receptor binding | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 4 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 1.07e-02 | 1.00e+00 | 3.651 | 2 | 15 | 164 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0005667 | transcription factor complex | 1.21e-02 | 1.00e+00 | 3.558 | 2 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.25e-02 | 1.00e+00 | 3.533 | 2 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 1.25e-02 | 1.00e+00 | 3.533 | 2 | 11 | 178 |
GO:0071480 | cellular response to gamma radiation | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0016746 | transferase activity, transferring acyl groups | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 13 |
GO:0005737 | cytoplasm | 1.35e-02 | 1.00e+00 | 1.130 | 8 | 124 | 3767 |
GO:0031011 | Ino80 complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 6 | 14 |
GO:0070542 | response to fatty acid | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 14 |
GO:0032993 | protein-DNA complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 2 | 14 |
GO:0042307 | positive regulation of protein import into nucleus | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 4 | 15 |
GO:0043011 | myeloid dendritic cell differentiation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0030225 | macrophage differentiation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0043981 | histone H4-K5 acetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 5 | 15 |
GO:0046849 | bone remodeling | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 15 |
GO:1990090 | cellular response to nerve growth factor stimulus | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0005730 | nucleolus | 1.57e-02 | 1.00e+00 | 1.650 | 5 | 66 | 1641 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 3 | 17 |
GO:0045773 | positive regulation of axon extension | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 18 |
GO:0033613 | activating transcription factor binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 3 | 18 |
GO:0030318 | melanocyte differentiation | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 3 | 19 |
GO:0043984 | histone H4-K16 acetylation | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 5 | 19 |
GO:0001227 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 2 | 19 |
GO:0035257 | nuclear hormone receptor binding | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 1 | 19 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 3 | 20 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0010942 | positive regulation of cell death | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 3 | 20 |
GO:0045648 | positive regulation of erythrocyte differentiation | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 1 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 3 | 21 |
GO:0045862 | positive regulation of proteolysis | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 21 |
GO:0003823 | antigen binding | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0043484 | regulation of RNA splicing | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 22 |
GO:0010508 | positive regulation of autophagy | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0045787 | positive regulation of cell cycle | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0001892 | embryonic placenta development | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 23 |
GO:0071479 | cellular response to ionizing radiation | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 23 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 2 | 23 |
GO:0043388 | positive regulation of DNA binding | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 24 |
GO:0043425 | bHLH transcription factor binding | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 24 |
GO:0016925 | protein sumoylation | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 25 |
GO:0051059 | NF-kappaB binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 25 |
GO:0035329 | hippo signaling | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 26 |
GO:0007040 | lysosome organization | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 1 | 26 |
GO:0043392 | negative regulation of DNA binding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 4 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 1 | 26 |
GO:0048565 | digestive tract development | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 2 | 26 |
GO:0006281 | DNA repair | 2.57e-02 | 1.00e+00 | 2.981 | 2 | 14 | 261 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 27 |
GO:0000077 | DNA damage checkpoint | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 27 |
GO:0034612 | response to tumor necrosis factor | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 27 |
GO:0071339 | MLL1 complex | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 6 | 27 |
GO:0043967 | histone H4 acetylation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 27 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.63e-02 | 1.00e+00 | 2.964 | 2 | 23 | 264 |
GO:0050714 | positive regulation of protein secretion | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 3 | 28 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2.78e-02 | 1.00e+00 | 5.151 | 1 | 2 | 29 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 30 |
GO:0042594 | response to starvation | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 4 | 31 |
GO:0043491 | protein kinase B signaling | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:0002062 | chondrocyte differentiation | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:0001756 | somitogenesis | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 1 | 33 |
GO:0071333 | cellular response to glucose stimulus | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 1 | 33 |
GO:0001085 | RNA polymerase II transcription factor binding | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 33 |
GO:0042692 | muscle cell differentiation | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 4 | 34 |
GO:0043010 | camera-type eye development | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 1 | 34 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 36 |
GO:0030218 | erythrocyte differentiation | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 1 | 37 |
GO:0032880 | regulation of protein localization | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 2 | 37 |
GO:0031490 | chromatin DNA binding | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 2 | 38 |
GO:0032092 | positive regulation of protein binding | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 1 | 38 |
GO:0046332 | SMAD binding | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 40 |
GO:0071320 | cellular response to cAMP | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 1 | 40 |
GO:0070301 | cellular response to hydrogen peroxide | 3.91e-02 | 1.00e+00 | 4.651 | 1 | 2 | 41 |
GO:0031124 | mRNA 3'-end processing | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 2 | 42 |
GO:0004402 | histone acetyltransferase activity | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 6 | 43 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 3 | 44 |
GO:0045165 | cell fate commitment | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 44 |
GO:0045727 | positive regulation of translation | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 2 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 2 | 45 |
GO:0043565 | sequence-specific DNA binding | 4.32e-02 | 1.00e+00 | 2.574 | 2 | 11 | 346 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 4 | 46 |
GO:0006959 | humoral immune response | 4.47e-02 | 1.00e+00 | 4.454 | 1 | 3 | 47 |
GO:0000902 | cell morphogenesis | 4.65e-02 | 1.00e+00 | 4.394 | 1 | 4 | 49 |
GO:0035690 | cellular response to drug | 4.65e-02 | 1.00e+00 | 4.394 | 1 | 3 | 49 |
GO:0006986 | response to unfolded protein | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 4.84e-02 | 1.00e+00 | 4.336 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 4.84e-02 | 1.00e+00 | 4.336 | 1 | 1 | 51 |
GO:0000910 | cytokinesis | 4.84e-02 | 1.00e+00 | 4.336 | 1 | 2 | 51 |
GO:0000226 | microtubule cytoskeleton organization | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 52 |
GO:0009611 | response to wounding | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 5 | 52 |
GO:0007623 | circadian rhythm | 5.03e-02 | 1.00e+00 | 4.281 | 1 | 1 | 53 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 5.03e-02 | 1.00e+00 | 4.281 | 1 | 5 | 53 |
GO:0051403 | stress-activated MAPK cascade | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 2 | 54 |
GO:0051592 | response to calcium ion | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 1 | 55 |
GO:0002039 | p53 binding | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 4 | 55 |
GO:0071300 | cellular response to retinoic acid | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 1 | 55 |
GO:0043627 | response to estrogen | 5.30e-02 | 1.00e+00 | 4.201 | 1 | 5 | 56 |
GO:0005643 | nuclear pore | 5.40e-02 | 1.00e+00 | 4.176 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 5 | 59 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 5 | 59 |
GO:0008013 | beta-catenin binding | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 9 | 60 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 2 | 61 |
GO:0032481 | positive regulation of type I interferon production | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 6 | 61 |
GO:0006406 | mRNA export from nucleus | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 4 | 61 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 5.86e-02 | 1.00e+00 | 4.055 | 1 | 3 | 62 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5.95e-02 | 1.00e+00 | 4.031 | 1 | 4 | 63 |
GO:0006310 | DNA recombination | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 7 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 4 | 65 |
GO:0010468 | regulation of gene expression | 6.40e-02 | 1.00e+00 | 3.921 | 1 | 2 | 68 |
GO:0018105 | peptidyl-serine phosphorylation | 6.50e-02 | 1.00e+00 | 3.900 | 1 | 2 | 69 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 6.68e-02 | 1.00e+00 | 3.859 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 6.68e-02 | 1.00e+00 | 3.859 | 1 | 4 | 71 |
GO:0060021 | palate development | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 1 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 4 | 72 |
GO:0030324 | lung development | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 1 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 6.86e-02 | 1.00e+00 | 3.819 | 1 | 4 | 73 |
GO:0000785 | chromatin | 6.86e-02 | 1.00e+00 | 3.819 | 1 | 6 | 73 |
GO:0006914 | autophagy | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 3 | 74 |
GO:0002020 | protease binding | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 1 | 75 |
GO:0007265 | Ras protein signal transduction | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 3 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 7.13e-02 | 1.00e+00 | 3.761 | 1 | 3 | 76 |
GO:0001889 | liver development | 7.22e-02 | 1.00e+00 | 3.742 | 1 | 3 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 7.31e-02 | 1.00e+00 | 3.723 | 1 | 7 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 7.31e-02 | 1.00e+00 | 3.723 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 7.40e-02 | 1.00e+00 | 3.705 | 1 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 7.40e-02 | 1.00e+00 | 3.705 | 1 | 2 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 5 | 80 |
GO:0044267 | cellular protein metabolic process | 7.56e-02 | 1.00e+00 | 2.120 | 2 | 20 | 474 |
GO:0071222 | cellular response to lipopolysaccharide | 7.59e-02 | 1.00e+00 | 3.669 | 1 | 4 | 81 |
GO:0009653 | anatomical structure morphogenesis | 7.77e-02 | 1.00e+00 | 3.634 | 1 | 2 | 83 |
GO:0009887 | organ morphogenesis | 8.04e-02 | 1.00e+00 | 3.582 | 1 | 5 | 86 |
GO:0045471 | response to ethanol | 8.04e-02 | 1.00e+00 | 3.582 | 1 | 3 | 86 |
GO:0000922 | spindle pole | 8.13e-02 | 1.00e+00 | 3.566 | 1 | 4 | 87 |
GO:0050821 | protein stabilization | 8.21e-02 | 1.00e+00 | 3.549 | 1 | 3 | 88 |
GO:0016605 | PML body | 8.21e-02 | 1.00e+00 | 3.549 | 1 | 3 | 88 |
GO:0000187 | activation of MAPK activity | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 3 | 90 |
GO:0006928 | cellular component movement | 8.48e-02 | 1.00e+00 | 3.501 | 1 | 3 | 91 |
GO:0001649 | osteoblast differentiation | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 5 | 92 |
GO:0071456 | cellular response to hypoxia | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 3 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 7 | 92 |
GO:0005770 | late endosome | 8.66e-02 | 1.00e+00 | 3.470 | 1 | 2 | 93 |
GO:0034142 | toll-like receptor 4 signaling pathway | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 4 | 96 |
GO:0001934 | positive regulation of protein phosphorylation | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 5 | 104 |
GO:0006935 | chemotaxis | 9.73e-02 | 1.00e+00 | 3.294 | 1 | 3 | 105 |
GO:0003676 | nucleic acid binding | 9.90e-02 | 1.00e+00 | 3.267 | 1 | 2 | 107 |
GO:0006915 | apoptotic process | 9.91e-02 | 1.00e+00 | 1.892 | 2 | 12 | 555 |
GO:0042127 | regulation of cell proliferation | 1.01e-01 | 1.00e+00 | 3.241 | 1 | 4 | 109 |
GO:0002224 | toll-like receptor signaling pathway | 1.01e-01 | 1.00e+00 | 3.241 | 1 | 4 | 109 |
GO:0030529 | ribonucleoprotein complex | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 5 | 112 |
GO:0006461 | protein complex assembly | 1.03e-01 | 1.00e+00 | 3.214 | 1 | 4 | 111 |
GO:0006006 | glucose metabolic process | 1.09e-01 | 1.00e+00 | 3.126 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 1.10e-01 | 1.00e+00 | 3.102 | 1 | 5 | 120 |
GO:0045087 | innate immune response | 1.12e-01 | 1.00e+00 | 1.790 | 2 | 15 | 596 |
GO:0007050 | cell cycle arrest | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 5 | 124 |
GO:0000790 | nuclear chromatin | 1.18e-01 | 1.00e+00 | 2.998 | 1 | 6 | 129 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.24e-01 | 1.00e+00 | 2.921 | 1 | 4 | 136 |
GO:0045202 | synapse | 1.24e-01 | 1.00e+00 | 2.921 | 1 | 5 | 136 |
GO:0016055 | Wnt signaling pathway | 1.26e-01 | 1.00e+00 | 2.900 | 1 | 4 | 138 |
GO:0007507 | heart development | 1.27e-01 | 1.00e+00 | 2.890 | 1 | 7 | 139 |
GO:0010628 | positive regulation of gene expression | 1.33e-01 | 1.00e+00 | 2.819 | 1 | 7 | 146 |
GO:0007166 | cell surface receptor signaling pathway | 1.34e-01 | 1.00e+00 | 2.809 | 1 | 4 | 147 |
GO:0001666 | response to hypoxia | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 7 | 149 |
GO:0006397 | mRNA processing | 1.45e-01 | 1.00e+00 | 2.687 | 1 | 10 | 160 |
GO:0043687 | post-translational protein modification | 1.46e-01 | 1.00e+00 | 2.669 | 1 | 5 | 162 |
GO:0031965 | nuclear membrane | 1.51e-01 | 1.00e+00 | 2.616 | 1 | 10 | 168 |
GO:0007049 | cell cycle | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 6 | 174 |
GO:0006351 | transcription, DNA-templated | 1.59e-01 | 1.00e+00 | 1.096 | 3 | 57 | 1446 |
GO:0032403 | protein complex binding | 1.64e-01 | 1.00e+00 | 2.493 | 1 | 6 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.65e-01 | 1.00e+00 | 2.485 | 1 | 22 | 184 |
GO:0001525 | angiogenesis | 1.70e-01 | 1.00e+00 | 2.431 | 1 | 7 | 191 |
GO:0030168 | platelet activation | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 6 | 205 |
GO:0019221 | cytokine-mediated signaling pathway | 1.94e-01 | 1.00e+00 | 2.221 | 1 | 8 | 221 |
GO:0016071 | mRNA metabolic process | 1.96e-01 | 1.00e+00 | 2.208 | 1 | 8 | 223 |
GO:0030425 | dendrite | 2.02e-01 | 1.00e+00 | 2.163 | 1 | 6 | 230 |
GO:0007399 | nervous system development | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 6 | 231 |
GO:0005829 | cytosol | 2.13e-01 | 1.00e+00 | 0.723 | 4 | 86 | 2496 |
GO:0043025 | neuronal cell body | 2.13e-01 | 1.00e+00 | 2.072 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.15e-01 | 1.00e+00 | 2.060 | 1 | 8 | 247 |
GO:0000166 | nucleotide binding | 2.24e-01 | 1.00e+00 | 1.992 | 1 | 13 | 259 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.32e-01 | 1.00e+00 | 1.937 | 1 | 7 | 269 |
GO:0006954 | inflammatory response | 2.38e-01 | 1.00e+00 | 1.895 | 1 | 6 | 277 |
GO:0043234 | protein complex | 2.51e-01 | 1.00e+00 | 1.804 | 1 | 11 | 295 |
GO:0005739 | mitochondrion | 2.52e-01 | 1.00e+00 | 1.046 | 2 | 23 | 998 |
GO:0035556 | intracellular signal transduction | 2.57e-01 | 1.00e+00 | 1.766 | 1 | 9 | 303 |
GO:0004674 | protein serine/threonine kinase activity | 2.61e-01 | 1.00e+00 | 1.742 | 1 | 6 | 308 |
GO:0008283 | cell proliferation | 2.75e-01 | 1.00e+00 | 1.651 | 1 | 14 | 328 |
GO:0046982 | protein heterodimerization activity | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 3.20e-01 | 1.00e+00 | 1.398 | 1 | 15 | 391 |
GO:0009986 | cell surface | 3.27e-01 | 1.00e+00 | 1.358 | 1 | 9 | 402 |
GO:0043066 | negative regulation of apoptotic process | 3.42e-01 | 1.00e+00 | 1.281 | 1 | 16 | 424 |
GO:0007596 | blood coagulation | 3.62e-01 | 1.00e+00 | 1.179 | 1 | 11 | 455 |
GO:0005524 | ATP binding | 3.63e-01 | 1.00e+00 | 0.667 | 2 | 31 | 1298 |
GO:0042802 | identical protein binding | 3.80e-01 | 1.00e+00 | 1.090 | 1 | 19 | 484 |
GO:0016032 | viral process | 4.10e-01 | 1.00e+00 | 0.948 | 1 | 26 | 534 |
GO:0016020 | membrane | 4.98e-01 | 1.00e+00 | 0.294 | 2 | 46 | 1681 |
GO:0007165 | signal transduction | 5.97e-01 | 1.00e+00 | 0.184 | 1 | 13 | 907 |
GO:0008270 | zinc ion binding | 6.33e-01 | 1.00e+00 | 0.047 | 1 | 27 | 997 |
GO:0070062 | extracellular vesicular exosome | 9.22e-01 | 1.00e+00 | -1.220 | 1 | 57 | 2400 |